New brain filter aims to prevent strokes during heart procedure
NCT ID NCT06689839
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tests a new device called the Encompass F2, which is designed to catch debris that might travel to the brain during a common heart valve replacement procedure (TAVR). The goal is to see if it reduces the risk of stroke and brain damage compared to standard care. About 500 patients with aortic stenosis will be randomly assigned to receive the F2 device or standard care, and their outcomes will be tracked.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- F2 Filter and Delivery System (a cerebral protection device)
- What this could lead to
- If it works, this device could lower the chance of stroke and brain injury during TAVR, making the procedure safer for patients with aortic stenosis.
- What could go wrong
- This is an early-stage device trial with no phase designation, so results may not confirm benefit. There is also a risk of complications from the device itself, such as vascular injury or device-related stroke.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 500 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Sep 2025
- Expected to finish
-
Jan 2027
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
50 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Key Inclusion Criteria: * Age ≥ 50 years. * Patient meets the established criteria and indications for commercially available TAVR via transfemoral access and is scheduled to undergo TAVR per their treating physician. * Patient is willing and able to comply with protocol-specified follow-up evaluations. * Patient is able and willing to provide written informed consent. * Patient meets all criteria for use of control device (Sentinel device, per IFU). Key Exclusion Criteria: General Exclusion Criteria: * Patient requires an urgent or emergent TAVR procedure. * Any interventional cardiovascular procedure performed within 30 days prior to TAVR procedure or planned within 30 days post-TAVR procedure. * Diagnostic cardiac catheterization within 10 days prior to TAVR procedure. * Evidence of an acute myocardial infarction within 3 months prior to TAVR procedure. * Prior prosthetic heart valve in any position. * Known intracardiac thrombus. * Active infection or endocarditis. * Patient is contraindicated for anti-platelet and/or anticoagulant therapy. * Patient refuses blood transfusion. * Renal insufficiency (creatinine \> 2.5 mg/dL or GFR \< 30) and/or renal replacement therapy at the time of screening. * Patients with hepatic failure (Child-Pugh class C). * Severe ventricular dysfunction with left ventricular ejection fraction (LVEF) \< 30%. * Females who are pregnant or nursing or plan to become pregnant during their participation in the study. Neurological Exclusion Criteria: * Modified Rankin Scale (mRS) ≥ 2 at screening. * Cerebrovascular event including TIA within 6 months of the procedure. * Patient has active major psychiatric disease, known mental or physical illness or known history of substance abuse that may cause non-compliance with the protocol or confound the data interpretation. * Patient has severe visual, auditory, or learning impairment. * Patient has neurodegenerative or other progressive neurological disease or history of significant head trauma followed by persistent neurologic defaults or known structural brain abnormalities. Magnetic Resonance Imaging Exclusion Criteria: * Contraindications to MRI (participants with MR unsafe implants including implantable temporary or permanent pacemaker or defibrillator, metal implants in field of view, metallic fragments, clips, or devices in the brain or eye before TAVR procedure). * High risk of complete AV block after TAVR, with the need of permanent pacemaker. * Claustrophobia precluding MRI scanning. Anatomical and CT Exclusion Criteria: * Severe peripheral arterial, abdominal aortic, or thoracic aortic disease that precludes delivery sheath, vascular access or filter deployment. * Presence of cardiovascular implant in aorta and/or peripheral access vessels. * Access vessels with excessive tortuosity. * Aortic arch, which is heavily calcified, severely atheromatous, or severely tortuous.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Aortic diseases are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
10 sites in 2 countries. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Cleveland Clinic Foundation
RECRUITINGCleveland, Ohio, 44195, United States
-
Cumc/Nyph
RECRUITINGNew York, New York, 10032, United States
-
Henry Ford Hospital
RECRUITINGDetroit, Michigan, 48202, United States
-
Monash Health Public
RECRUITINGClayton, Victoria, 3168, Australia
-
NCH Baker Hospital-Naples Heart Institute
NOT_YET_RECRUITINGNaples, Florida, 34102, United States
-
Ohio Health Research Institute (aka Riverside Methodist Hospital)
NOT_YET_RECRUITINGColumbus, Ohio, 43214, United States
-
St Andrews War Memorial Hospital
NOT_YET_RECRUITINGSpring Hill, Queensland, 4000, Australia
-
St. Lukes Hospital Of Kansas City
RECRUITINGKansas City, Missouri, 64111, United States
-
St. Vincent Hospital
RECRUITINGIndianappolis, Indiana, 46260, United States
-
University of Virginia Medical Center
NOT_YET_RECRUITINGCharlottesville, Virginia, 22903, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Eye ultrasound may spot brain swelling during aortic surgery
- Can Real-World data improve vascular surgery outcomes?
- Prepping the body before heart surgery: could exercise shorten hospital stays?
- Massive heart surgery database aims to save lives through data
- Heart valve mystery: scientists hunt for genetic clues in 1,000 patients
- New tool may prevent artery blockage during heart valve replacement